Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-29

Clinical Trial Update: Role of ASpirin in Placental and Maternal Endothelial Cell Regulation IN Pre-eclampsia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating aspirin's role in regulating placental and maternal endothelial cells in preeclampsia; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: John O'Brien, MD | Conditions: Pre-Eclampsia | Phase 2 | Status: COMPLETED | Results posted: 2025-08-29